 |
FSD Pharma
HUGE
|
172 |
- |
5743.5 % |
$ 69.7 M |
Canada |
 |
MorphoSys AG
MOR
|
1.75 |
- |
2.43 % |
$ 254 M |
Germany |
 |
Happiness Biotech Group Limited
HAPP
|
0.429 |
- |
1.35 % |
$ 17.8 M |
China |
 |
AgeX Therapeutics
AGE
|
9.24 |
- |
-10.17 % |
$ 12.2 K |
USA |
 |
I-Mab
IMAB
|
94.1 |
- |
- |
$ 866 M |
China |
 |
Autolus Therapeutics plc
AUTL
|
4.27 |
$ 1.7 |
3.03 % |
$ 452 M |
Britain |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 |
- |
- |
$ 40.3 B |
USA |
 |
Genfit SA
GNFT
|
1.96 K |
- |
2.54 % |
$ 160 B |
France |
 |
BioNTech SE
BNTX
|
35.7 |
$ 92.14 |
1.33 % |
$ 22.3 B |
Germany |
 |
AstraZeneca PLC
AZN
|
2.13 |
- |
- |
$ 96.9 B |
Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K |
- |
-1.52 % |
$ 24.7 M |
USA |
 |
Compugen Ltd.
CGEN
|
2.7 |
$ 2.8 |
7.28 % |
$ 262 M |
Israel |
 |
Abcam plc
ABCM
|
13.7 |
- |
- |
$ 4.9 B |
Britain |
 |
Midatech Pharma plc
MTP
|
240 |
- |
-18.52 % |
$ 27.3 M |
Britain |
 |
Affimed N.V.
AFMD
|
13.1 |
- |
-34.95 % |
$ 21.5 M |
Germany |
 |
Институт стволовых клеток человека
ISKJ
|
2.61 |
- |
- |
- |
Russia |
 |
Celyad Oncology SA
CYAD
|
21.3 K |
- |
- |
$ 12.5 M |
Belgium |
 |
Berkeley Lights
BLI
|
1.49 |
- |
-7.31 % |
$ 87 M |
USA |
 |
Generation Bio Co.
GBIO
|
30.3 |
- |
- |
$ 344 M |
USA |
 |
IMV
IMV
|
48.2 |
- |
- |
$ 13.1 M |
Canada |
 |
Ayala Pharmaceuticals
AYLA
|
11.2 |
- |
- |
$ 7.46 M |
Israel |
 |
Cyclacel Pharmaceuticals
CYCCP
|
2.54 |
- |
-4.36 % |
$ 27 M |
USA |
 |
Coherus BioSciences
CHRS
|
5.36 |
$ 1.61 |
2.55 % |
$ 189 M |
USA |
 |
Anika Therapeutics
ANIK
|
1.9 |
$ 14.88 |
-0.93 % |
$ 213 M |
USA |
 |
Advaxis
ADXS
|
144 |
- |
-9.65 % |
$ 45.9 M |
USA |
 |
Aeterna Zentaris
AEZS
|
1.54 |
- |
5.93 % |
$ 314 M |
Canada |
 |
Aeglea BioTherapeutics
AGLE
|
489 |
- |
- |
$ 1.01 B |
USA |
 |
CureVac N.V.
CVAC
|
281 |
- |
- |
$ 867 M |
Germany |
 |
Applied Genetic Technologies Corporation
AGTC
|
41.6 |
- |
- |
$ 26.5 M |
USA |
 |
AIkido Pharma
AIKI
|
0.935 |
- |
1.93 % |
$ 17.4 M |
USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
11.9 |
$ 3.4 |
-1.16 % |
$ 5.6 M |
Israel |
 |
Aptinyx
APTX
|
204 |
- |
-39.0 % |
$ 4.57 M |
USA |
 |
Albireo Pharma
ALBO
|
13.5 |
- |
-0.23 % |
$ 916 M |
USA |
 |
Arcutis Biotherapeutics
ARQT
|
9.15 |
$ 20.86 |
-0.71 % |
$ 2.65 B |
USA |
 |
Ampio Pharmaceuticals
AMPE
|
236 |
- |
-11.43 % |
$ 502 K |
USA |
 |
Alpine Immune Sciences
ALPN
|
8.94 |
- |
- |
$ 2.17 B |
USA |